|
WO2020093162A1
|
|
Treatment of bet inhibitor-resistant cancers and other diseases responsive to dual bet and cbp/ep300 inhibition therapy
|
|
US2019031657A1
|
|
Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals
|
|
CA2953166A1
|
|
Matriptase inhibitors and uses thereof
|
|
US2018312504A1
|
|
Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors
|
|
US2018237417A1
|
|
Substituted benzimidazoles, their preparation and their use as pharmaceuticals
|
|
US2018230130A1
|
|
Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals
|
|
WO2017024406A1
|
|
N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals
|
|
US2015361078A1
|
|
Imidazopyridine compounds and uses thereof
|
|
TW200817338A
|
|
New benzimidazole derivatives 290
|
